Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Camille Ragin elected chair of AACR Minorities in Cancer Research Council

April 21, 2023
Vol.49 No.16
In Brief

African-Caribbean Cancer Consortium receives AACR Team Science Award

April 21, 2023
Vol.49 No.16
In Brief

Edna ‘Eti’ Cukierman appointed chair-elect of AACR’s Tumor Microenvironment Working Group

April 21, 2023
Vol.49 No.16
In Brief

AACR names fellows of the AACR Academy class of 2023

April 07, 2023
Vol.49 No.14
In Brief

Elizabeth M. Jaffee elected AACR Academy president

April 07, 2023
Vol.49 No.14
In Brief

Phyllis Pettit Nassi and Jane Perlmutter to receive AACR 2023 Distinguished Public Service Award

April 07, 2023
Vol.49 No.14
In Brief

Patricia M. LoRusso elected AACR president-elect for 2023-2024

March 24, 2023
Vol.49 No.12
In Brief

Elizabeth M. Jaffee to receive 2023 AACR-Margaret Foti Award

March 17, 2023
Vol.49 No.11
In Brief

Tak W. Mak selected for 2023 Pezcoller Foundation-AACR International Award

March 17, 2023
Vol.49 No.11
NIH, NCI face devastating cuts in debt ceiling fight; We must rally for biomedical research
Guest Editorial

NIH, NCI face devastating cuts in debt ceiling fight; We must rally for biomedical research

January 27, 2023
Vol.49 No.04
By Lisa M. Coussens

Posts navigation

Previous1…567…11Next

Trending Stories

  • Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
  • Pam Bondi diagnosed with thyroid cancer
  • The story of daraxonrasib is the ultimate hero’s journey
    A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
  • At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account